George G Nomikos

George G Nomikos

No open positions remaining
Health Technology
Consumer Services

Profile

George G Nomikos worked as a Scientific Director-Scientific Affairs at Amgen, Inc. from 2006 to 2007.
He also served as a Director-Scientific Affairs at Cynapsus Therapeutics, Inc. He was a Research Scientist-Neuroscience Discovery at Eli Lilly & Co. from 1998 to 2006.
Additionally, he worked as an Associate Professor at Karolinska Institutet.
Currently, he is the SVP-Medical & Clinical Science at Scholar Rock Holding Corp.
from 2019 to 2022.
He will be serving as the Chief Medical Officer at Lipocine, Inc. starting from 2022 to 2023.
Dr. Nomikos holds a doctorate degree from the University of British Columbia and the National & Kapodistrian University of Athens, which he received in 1987.

Former positions of George G Nomikos

CompaniesPositionEnd
LIPOCINE INC. Chief Tech/Sci/R&D Officer 01/04/2023
SCHOLAR ROCK HOLDING CORPORATION Chief Tech/Sci/R&D Officer 02/11/2022
AMGEN INC. Corporate Officer/Principal 01/10/2007
ELI LILLY AND COMPANY Corporate Officer/Principal 01/01/2006
Corporate Officer/Principal -
See the detail of George G Nomikos's experience

Training of George G Nomikos

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

87

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. George G Nomikos